track 3 - patients and caregivers: shaping clinical drug development
Published 4 years ago • 24 plays • Length 1:03:05Download video MP4
Download video MP3
Similar videos
-
1:05:12
track 3 - patients and advocates as entrepreneurs: new models for drug development
-
1:02:51
track 4 - technologies for learning about rare disease from patients and caregivers
-
1:02:23
track 3 - early drug development what patients bring
-
50:32
track 3: patients as investors
-
52:31
track 3: laying the foundation the role and goals of discovery and preclinical research
-
27:32
what level 3 extended health and social care diploma is really like || jessica-jayne
-
1:17:30
a new era of medicine with ips cells - lecture by professor shinya yamanaka
-
27:13
nvq 3 in health and social care
-
54:01
track 3: how a therapy gets developed and approved the r&d roadmap and the growing role of patients
-
1:01:02
rare drug development symposium: working with advocacy groups
-
48:00
track 3 2 30 clinical trial training pre drug deveopment
-
48:00
track 3 2 30 clinical trial training pre drug deveopment
-
1:02:45
track 3 - the value of rare disease therapies: patient perspectives needed
-
43:19
patient advocacy track: data strategy for research development – what do advocates need to know
-
51:26
young investigator track critical considerations collaborating with patients/patient advocacy groups
-
51:46
patient advocacy track preclinical modeling – what advocates need to know about animal & cell models
-
48:02
track 3: the drug re discovery pipline finding new indications for approved therapeutics
-
1:01:26
track 2: the promise and perils of working with industry lessons from avocacy group experience on a
-
1:01:48
building valuable registries and natural history studies
-
56:19
track 3: show your data what do you need to have before approaching industry
-
46:17
day 2: track 3, understanding expanded access, john lagus, steve walker, kristina broadbelt